SCP & CO Healthcare Acquisition Company Warrant
SHACW
SHACW was delisted on the 8th of December, 2022.
33 hedge funds and large institutions have $4.6M invested in SCP & CO Healthcare Acquisition Company Warrant in 2021 Q1 according to their latest regulatory filings, with 33 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Balyasny Asset Management
Chicago,
Illinois
|
+$532K |
| 2 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$532K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$220K |
| 4 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
+$154K |
| 5 |
RCM
Radcliffe Capital Management
Bala Cynwyd,
Pennsylvania
|
+$145K |
Top Sellers
SHACW Hedge Fund Activity: Q1 2021 in Review
33 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in SCP & CO Healthcare Acquisition Company Warrant (SHACW) for Q1 2021, worth a combined $4.6M.
Buyers outnumbered sellers: 33 funds opened new SHACW positions and 0 closed out — a net gain of 33 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Balyasny Asset Management, opening a new position worth an estimated $532K.
- 33 institutional investors held SCP & CO Healthcare Acquisition Company Warrant (SHACW) as of Q1 2021, up from 0 in Q4 2020.
- Funds reported $4.6M of SCP & CO Healthcare Acquisition Company Warrant stock for Q1 2021.
- 33 funds opened new SCP & CO Healthcare Acquisition Company Warrant positions in Q1 2021 and 0 closed out, a net change of +33 holders.
- The largest SCP & CO Healthcare Acquisition Company Warrant buyer in Q1 2021 was Balyasny Asset Management, an estimated $532K added.
Based on aggregated 13F filings for Q1 2021.